Cyclacillin: a clinical and in vitro profile.
D000328:Adult; D000667:Ampicillin / Q000627:therapeutic use; D001419:Bacteria / Q000187:drug effects / Q000276:immunology; D002481:Cellulitis / Q000188:drug therapy; D003514:Cyclohexylamines / Q000097:blood / Q000627:therapeutic use / Q000652:urine; D004341:Drug Evaluation; D004751:Enteritis / Q000188:drug therapy; D006801:Humans; D008297:Male; D008712:Methicillin / Q000627:therapeutic use; D010397:Penicillanic Acid / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use / Q000652:urine; D010400:Penicillin G / Q000627:therapeutic use; D010406:Penicillins / Q000097:blood / Q000627:therapeutic use* / Q000652:urine; D012141:Respiratory Tract Infections / Q000188:drug therapy; D013210:Staphylococcus / Q000187:drug effects / Q000276:immunology; D014552:Urinary Tract Infections / Q000188:drug therapy
D003514:Cyclohexylamines; D010406:Penicillins; D000667:Ampicillin; D010397:Penicillanic Acid; D010400:Penicillin G; D008712:Methicillin